- Home
- NDRA vs UPXI Comparison
NDRA vs UPXI Comparison
Compare NDRA & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- UPXI
- Stock Information
- Founded
- NDRA 2007
- UPXI 2018
- Country
- NDRA United States
- UPXI United States
- Employees
- NDRA N/A
- UPXI N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- NDRA Health Care
- UPXI Health Care
- Exchange
- NDRA Nasdaq
- UPXI Nasdaq
- Market Cap
- NDRA 5.1M
- UPXI 5.3M
- IPO Year
- NDRA 2017
- UPXI 2021
- Fundamental
- Price
- NDRA $4.54
- UPXI $4.10
- Analyst Decision
- NDRA Strong Buy
- UPXI Hold
- Analyst Count
- NDRA 1
- UPXI 1
- Target Price
- NDRA $14,000.00
- UPXI $25.00
- AVG Volume (30 Days)
- NDRA 709.8K
- UPXI 2.5M
- Earning Date
- NDRA 11-15-2024
- UPXI 11-29-2024
- Dividend Yield
- NDRA N/A
- UPXI N/A
- EPS Growth
- NDRA N/A
- UPXI N/A
- EPS
- NDRA N/A
- UPXI N/A
- Revenue
- NDRA N/A
- UPXI $83,980,115.00
- Revenue This Year
- NDRA N/A
- UPXI $18.98
- Revenue Next Year
- NDRA N/A
- UPXI $8.09
- P/E Ratio
- NDRA N/A
- UPXI N/A
- Revenue Growth
- NDRA N/A
- UPXI 27.11
- 52 Week Low
- NDRA $4.41
- UPXI $2.17
- 52 Week High
- NDRA $4,882.50
- UPXI $33.00
- Technical
- Relative Strength Index (RSI)
- NDRA 31.46
- UPXI 42.27
- Support Level
- NDRA $5.23
- UPXI $4.52
- Resistance Level
- NDRA $8.80
- UPXI $5.94
- Average True Range (ATR)
- NDRA 1.58
- UPXI 1.42
- MACD
- NDRA -0.06
- UPXI -0.34
- Stochastic Oscillator
- NDRA 1.73
- UPXI 0.58
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About UPXI Upexi Inc.
Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.